Etoricoxib (Arcoxia): recommended starting dose revised

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Etoricoxib, a COX-2 inhibitor has been linked to a possible increase in risk of coronary and cerebrovascular thrombotic events, heart failure, hypertension, and oedema. GI perforation, ulceration, or bleeding are other risks to be considered with etoricoxib therapy.

Trial results have shown that the 60-mg dose is effective...